Fundamental dimension Equity attribute | ACNTLeader $13.94▲+0.58% Cap $125.6MP/E -29.7x QuantScore50/100 | AVDPeer $1.03▼-2.83% Cap $30.39MP/E -0.5x QuantScore32/100 | BIOXPeer $0.2346▼-8.00% Cap $14.83MP/E -0.1x QuantScore36/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
59/100 |
23/100 |
21/100 |
Valuation Multiples, PEG & DCF upside | 25/100 | 0/100 | 40/100 |
Health Piotroski, Altman Z, leverage & liquidity | 66/100 | 28/100 | 3/100 |
Growth Revenue / earnings growth & margins | 25/100 | 29/100 | 26/100 |
Sentiment Analyst ratings, targets & revisions | 77/100 | 83/100 | 92/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -29.7x | -0.5x | -0.1x |
Forward P/E (next FY) | — | 2.7x | 4.7x |
EV / EBITDA (TTM) | 146.9x | -24.6x | 90.5x |
Price / Sales | 1.5x | 0.1x | 0.1x |
Price / Free Cash Flow | -14.9x | -0.6x | 0.3x |
PEG ratio | 0.02 | -0.01 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 3 / 9 | 3 / 9 |
Altman Z-Score | 4.65 (Safe) | 1.47 (Distress) | 0.36 (Distress) |
Total debt / equity | 0.17 | 1.57 | 6.06 |
Quick ratio | 3.6x | 1.4x | 0.6x |
Interest coverage | — | 0.2x | -0.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -57.9% | -5.9% | -28.7% |
Net income growth YoY | +58.9% | +60.5% | -315.6% |
Gross margin (TTM) | 20.8% | 29.4% | 35.4% |
Operating margin (FY) | -9.0% | 2.7% | 0.0% |
FCF margin (FY) | -2.8% | -4.9% | 14.8% |
5. Trailing price performancePrice change over period |
1M return | -5.2% | -46.6% | -36.8% |
3M return | -7.9% | -59.9% | -31.6% |
6M return | -4.0% | -65.2% | -56.7% |
Year to date | -13.9% | -73.0% | -82.1% |
1Y return | +14.2% | -80.7% | -87.3% |
3Y return | +69.0% | -88.5% | -97.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $8.50 -39.1% premium | $-0.4168 -140.5% premium | $-2.10 -993.1% premium |
Wall Street consensus target | $18.00 +29.1% · range $18.00–$18.00 | $17.00 +1550.5% · range $14.00–$20.00 | $8.00 +3310.1% · range $2.00–$15.00 |
Consensus stance | 75% Buy25% Hold0% Sell | 69% Buy31% Hold0% Sell | 80% Buy20% Hold0% Sell |